Andrew Farnum

CEO at Variant Bio


Andrew Farnum has had a long and successful career in the medical research industry. Andrew began their career as an investment manager at the Children's Investment Fund Foundation. Andrew then moved on to the Bill & Melinda Gates Foundation, where they served as the director of the Gates Foundation Strategic Investment Fund. In this role, they were responsible for leading the Gates Foundation's $2 billion strategic investment fund.

In January 2018, Farnum joined the Board of Directors of the Bill & Melinda Gates Medical Research Institute. Andrew served in this role for three years before being appointed as the CEO of Variant Bio in December 2020.

Tom Rush - Chief R&D Officer, Gregory Tranah - VP, Medical Biology, and Holly Vance - General Counsel report to Andrew Farnum.



  • CEO

    Current role

View in org chart

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.